Segment Reporting - Schedule of Segment Reporting Presents Reportable Segment Profit and Loss (Parenthetical) (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Equity-based compensation expense | $ 15,415 | $ 14,341 | $ 29,649 | $ 26,309 |
| Impairment of long-lived assets | 4,900 | |||
| Depreciation expense | 1,700 | 1,900 | 3,300 | 3,400 |
| Research and Development Expense | ||||
| Equity-based compensation expense | 8,037 | 7,257 | 15,583 | 13,340 |
| General and Administrative | ||||
| Equity-based compensation expense | $ 7,378 | $ 7,084 | $ 14,066 | $ 12,969 |
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|